Euvichol-S | Cholera

• Context (FE): WHO prequalifies new oral vaccine for cholera, Euvichol-S.
• The new vaccine is the third product of the same family of vaccines for cholera in the WHO prequalification list, Euvichol and Euvichol-Plus.
• Euvichol-S is a simplified formulation of the oral cholera vaccine (OCV) Euvichol-Plus.
• The vaccine is manufactured by South Korea-based EuBiologics Co., Ltd. (EuBiologics is the largest supplier of oral cholera vaccine in the world, representing more than 80% market share).

Cholera

• Cholera is an acute, diarrheal illness caused by infection of the intestine with the toxigenic bacterium Vibrio cholerae.
• The cholera bacterium is usually found in water or in foods that have been contaminated by feces from a person infected with cholera bacteria.
• Spread: It is most likely to occur and spread in places with inadequate water treatment, poor sanitation, and inadequate hygiene.
• Symptoms: Rapid heart rate, loss of skin elasticity (the ability to return to original position quickly if pinched), dry mucous membranes, low blood pressure, thirst, muscle cramps.